Friday, February 25, 2011

MARKET VIEW FOR 25TH FEBRUARY 2011

TODAY ALSO SETTLEMENT PRICE ANALYSIS WENT WRONG.IT WAS DUE TECHNICAL FACTOR THAT THERE WAS SUDDEN HUGE UNWINDING OF THE PUTs WRITTEN AT 5400 & 5300 AND THIS WAS DUE TO TENSIONS IN MIDDLE-EAST COUNTRIES, AND SUDDEN RISE IN THE CRUDE OIL ABOVE $100. THIS MADE FIIs TRIGGER THE SELL BEFORE THE BUDGET.MOREOVER THE GEO-POLITICAL SITUATION, FOOD INFLATION DATA, AND POOR SENTIMENTS FOR EMs HAVE BEEN THE BASIC REASONS FOR THE PANIC SELLING IN THE MARKETS.


NOW WHEN NIFTY HAS BREACHED 5300, AS IT HAS BEEN ALREADY MENTIONED IN PAST SEVERAL TIMES THAT NIFTY IS HEADING LOWER TO 5000 LEVELS AND MORE DOWN, ONE SHOULD AVOID BUYING AT THIS TIME AND HOLD CASH TO BUY WHEN MARKET GIVES OPPORTUNITY.


THOSE WHO HAVE BOUGHT PUTs AT 5400 LEVELS AND ABOVE SHOULD BOOK PARTIAL PROFITS AND WAIT FOR MARKET TO BOUNCE LITTLE BIT SO THAT ONCE AGAIN PUTs ARE BOUGHT AT THE LOWER PRICES.HENCE KEEPING THE NEGATIVE VIEW IN THE SHORT TERM


THOSE INTERESTED IN AGGRESSIVE TRADING WATCH OUT TO BUY FOR BUDGET DAY:


RETAILS LIKE PANTALOON, TRENT ETC
FERTILISER LIKE COROMONDAL FERT, NATIONAL FERT, ETC
EDUCATION LIKE EVERONN, EDUCOMP, CORE PROJECT, NIIT ETC
PHARMA LIKE CIPLA, RANBAXY, LUPIN ETC
JEWELLERY & EXPORTS LIKE TITAN, GITANJALI, ETC



FOLLOWING STOCKS SHOULD BE WATCHED TODAY FOR THE PRICE ACTION:

1. JINDAL SAW(207.25): UPWARD PRICE ACTION MAY BE SEEN TILL 220-30.

2. DIVIS LAB(606.35):UPWARD PRICE ACTION MAY BE SEEN TILL 620-30.

3.L&T(1516.40):
UPWARD PRICE ACTION MAY BE SEEN TILL 620-30.

Safe Harbor Statement:
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.

Disclaimer: 
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.




No comments:

Post a Comment

Note: Only a member of this blog may post a comment.